Skip to content

Clinical trials

Completed Phase 2 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2 Status: Completed Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
200512
20064
20076
20087
200911
20106
20113
20127
20134
20147
20153
20163
20171
20182
20191
20202
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed90

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)11
Allergy Therapeutics9
Circassia Limited7
ALK-Abelló A/S5
Aerovance, Inc.4
Roxall Medicina España S.A4
Genentech, Inc.3
Johns Hopkins University2
Novartis Pharmaceuticals2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity90
Asthma17
Hypersensitivity, Immediate14
Rhinitis, Allergic12
Rhinitis, Allergic, Seasonal11
Rhinitis10
Food Hypersensitivity9
Peanut Hypersensitivity9
Immune System Diseases5
Eczema4

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.